12:00 AM
 | 
Jul 13, 2009
 |  BC Week In Review  |  Company News  |  Deals

Repros, NIH deal

Repros (formerly Zonagen Inc.) and NIH amended for a sixth time a 1999 deal giving the company rights to Proellex ( CDB-4124)....

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >